Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Interest & Investment Income (2016 - 2026)

Rockwell Medical filings provide 16 years of Interest & Investment Income readings, the most recent being $44000.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 51.72% to $44000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $234000.0, a 154.35% increase, with the full-year FY2025 number at $234000.0, up 154.35% from a year prior.
  • Interest & Investment Income hit $44000.0 in Q4 2025 for Rockwell Medical, down from $55000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $69000.0 in Q2 2025 to a low of -$6000.0 in Q3 2022.
  • Median Interest & Investment Income over the past 5 years was $42000.0 (2023), compared with a mean of $35117.6.
  • Biggest five-year swings in Interest & Investment Income: plummeted 93.57% in 2021 and later skyrocketed 1033.33% in 2023.
  • Rockwell Medical's Interest & Investment Income stood at $5000.0 in 2021, then soared by 760.0% to $43000.0 in 2022, then decreased by 2.33% to $42000.0 in 2023, then plummeted by 30.95% to $29000.0 in 2024, then skyrocketed by 51.72% to $44000.0 in 2025.
  • The last three reported values for Interest & Investment Income were $44000.0 (Q4 2025), $55000.0 (Q3 2025), and $69000.0 (Q2 2025) per Business Quant data.